Letter to the Editor on “Normal-weight MASLD: reclassification, characteristics, and adverse liver outcomes across diverse populations”
Clinical and Molecular Hepatology · 06.11.2026
DOI: 10.3350/cmh.2026.0301 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 06.11.2026. Verfasst von Yixuan Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Infectious Diseases, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
- Department of Infectious Diseases, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China. lijier@nju.edu.cn.
Zitieren
APA
Zhu, Y., & Li, J. (2026). Letter to the Editor on “Normal-weight MASLD: reclassification, characteristics, and adverse liver outcomes across diverse populations”. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0301
Vancouver
Zhu Y, Li J. Letter to the Editor on “Normal-weight MASLD: reclassification, characteristics, and adverse liver outcomes across diverse populations”. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.0301
BibTeX
@article{Zhu2026,
author = {Zhu, Yixuan and Li, Jie},
title = {Letter to the Editor on “Normal-weight MASLD: reclassification, characteristics, and adverse liver outcomes across diverse populations”},
journal = {Clinical and Molecular Hepatology},
year = {2026},
doi = {10.3350/cmh.2026.0301}
}
EUVIMED